These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 19167723)

  • 21. Risk factor analysis of outcomes after unrelated cord blood transplantation in patients with hurler syndrome.
    Boelens JJ; Rocha V; Aldenhoven M; Wynn R; O'Meara A; Michel G; Ionescu I; Parikh S; Prasad VK; Szabolcs P; Escolar M; Gluckman E; Cavazzana-Calvo M; Kurtzberg J;
    Biol Blood Marrow Transplant; 2009 May; 15(5):618-25. PubMed ID: 19361754
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Allogeneic stem cell transplantation for myelodysplastic syndromes in children: a report from the Spanish Working Party for Blood and Marrow Transplantation in Children (GETMON).
    Muñoz A; Díaz-Heredia C; Badell I; Bureo E; Gómez P; Martínez A; Verdeguer A; Pérez-Hurtado JM; Fernández-Delgado R; González-Vicent M; Maldonado MS
    Pediatr Hematol Oncol; 2009; 26(5):345-55. PubMed ID: 19579081
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Prevalence and characterization of cardiac involvement in Hunter syndrome.
    Kampmann C; Beck M; Morin I; Loehr JP
    J Pediatr; 2011 Aug; 159(2):327-31.e2. PubMed ID: 21529823
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Early response to idursulfase treatment in a 3 year-old boy affected of Hunter syndrome.
    Galán-Gómez E; Guerrero-Rico A; Cáceres-Marzal C; Zambrano-Castaño M; Moreno-Tejero ML; Grande-Tejada AM; Fernández-Hernández S; Vaquerizo-Madrid J; Cardesa-García JJ
    Eur J Med Genet; 2008; 51(3):268-71. PubMed ID: 18396123
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Platelet engraftment in patients with hematologic malignancies following unmanipulated haploidentical blood and marrow transplantation: effects of CD34+ cell dose and disease status.
    Chang YJ; Xu LP; Liu DH; Liu KY; Han W; Chen YH; Yu-Wang ; Chen H; Wang JZ; Zhang XH; Zhao XY; Huang XJ
    Biol Blood Marrow Transplant; 2009 May; 15(5):632-8. PubMed ID: 19361756
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effect of donor chimerism to reduce the level of glycosaminoglycans following bone marrow transplantation in a murine model of mucopolysaccharidosis type II.
    Yokoi K; Akiyama K; Kaneshiro E; Higuchi T; Shimada Y; Kobayashi H; Akiyama M; Otsu M; Nakauchi H; Ohashi T; Ida H
    J Inherit Metab Dis; 2015 Mar; 38(2):333-40. PubMed ID: 25503568
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Matched unrelated bone marrow transplant for T+ combined immunodeficiency.
    Roifman CM; Somech R; Grunebaum E
    Bone Marrow Transplant; 2008 Jun; 41(11):947-52. PubMed ID: 18264145
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Multidisciplinary management of Hunter syndrome.
    Muenzer J; Beck M; Eng CM; Escolar ML; Giugliani R; Guffon NH; Harmatz P; Kamin W; Kampmann C; Koseoglu ST; Link B; Martin RA; Molter DW; Muñoz Rojas MV; Ogilvie JW; Parini R; Ramaswami U; Scarpa M; Schwartz IV; Wood RE; Wraith E
    Pediatrics; 2009 Dec; 124(6):e1228-39. PubMed ID: 19901005
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Outcome in six children with mucopolysaccharidosis type IH, Hurler syndrome, after haematopoietic stem cell transplantation (HSCT).
    Malm G; Gustafsson B; Berglund G; Lindström M; Naess K; Borgström B; von Döbeln U; Ringdén O
    Acta Paediatr; 2008 Aug; 97(8):1108-12. PubMed ID: 18452566
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Successful bone marrow transplantation in an 8-month-old patient with chronic granulomatous disease.
    Kansoy S; Kütükçüler N; Aksoylar S; Aksu G; Kantar M; Cetingül N
    Turk J Pediatr; 2006; 48(3):253-5. PubMed ID: 17172071
    [TBL] [Abstract][Full Text] [Related]  

  • 31. HLA-haploidentical blood and bone marrow transplantation with anti-thymocyte globulin: long-term comparison with HLA-identical sibling transplantation.
    Chen XH; Gao L; Zhang X; Gao L; Zhang C; Kong PY; Liu H; Peng XG; Sun AH; Qi DG; Gong Y; Wang QY
    Blood Cells Mol Dis; 2009; 43(1):98-104. PubMed ID: 19356956
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Donor KIR3DL1/3DS1 gene and recipient Bw4 KIR ligand as prognostic markers for outcome in unrelated hematopoietic stem cell transplantation.
    Gagne K; Busson M; Bignon JD; Balère-Appert ML; Loiseau P; Dormoy A; Dubois V; Perrier P; Jollet I; Bois M; Masson D; Moine A; Absi L; Blaise D; Charron D; Raffoux C;
    Biol Blood Marrow Transplant; 2009 Nov; 15(11):1366-75. PubMed ID: 19822295
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Haploidentical hematopoietic stem cell transplantation in child hematologic malignancies with G-CSF-mobilized marrow grafts without T-cell depletion: a single-center report of 45 cases.
    Wang HX; Yan HM; Duan LN; Wang ZD; Zhu L; Xue M; Liu J; Hu LD; Guo ZK
    Pediatr Hematol Oncol; 2009; 26(3):119-28. PubMed ID: 19382033
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Follow-up of patients with Hunter syndrome: the Hunter Outcome Survey (HOS) registry].
    del Toro-Riera M
    Rev Neurol; 2007 Feb; 44 Suppl 1():S13-7. PubMed ID: 17345554
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Bone marrow transplantation for aspartylglucosaminuria: follow-up study of transplanted and non-transplanted patients.
    Arvio M; Sauna-Aho O; Peippo M
    J Pediatr; 2001 Feb; 138(2):288-90. PubMed ID: 11174635
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Recognition and diagnosis of mucopolysaccharidosis II (Hunter syndrome).
    Martin R; Beck M; Eng C; Giugliani R; Harmatz P; Muñoz V; Muenzer J
    Pediatrics; 2008 Feb; 121(2):e377-86. PubMed ID: 18245410
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A modified haploidentical nonmyeloablative transplantation without T cell depletion for high-risk acute leukemia: successful engraftment and mild GVHD.
    Guo M; Sun Z; Sun QY; Han Q; Yu CL; Wang DH; Qiao JH; Chen B; Sun WJ; Hu KX; Liu GX; Liu B; Zhao RC; Ai H
    Biol Blood Marrow Transplant; 2009 Aug; 15(8):930-7. PubMed ID: 19589482
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Overcoming various comorbidities by G-CSF-primed unmanipulated BM SCT in adult patients with AML.
    Kim HJ; Min WS; Cho BS; Eom KS; Kim SY; Kim YJ; Lee S; Min CK; Cho SG; Lee JW; Kim CC
    Bone Marrow Transplant; 2009 Sep; 44(6):345-51. PubMed ID: 19270728
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cellular immune reconstitution and its impact on clinical outcome in children with beta thalassemia major undergoing a matched related myeloablative allogeneic bone marrow transplant.
    Rajasekar R; Mathews V; Lakshmi KM; George B; Viswabandya A; Chandy M; Srivastava A
    Biol Blood Marrow Transplant; 2009 May; 15(5):597-609. PubMed ID: 19361752
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Second allogeneic stem cell transplantation in myeloid malignancies.
    Hartwig M; Ocheni S; Asenova S; Wiedemann B; Zabelina T; Ayuk F; Kabisch H; Erttmann R; Kröger N; Zander AR; Bacher U
    Acta Haematol; 2009; 122(4):185-92. PubMed ID: 19887774
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.